HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Women's heart failure: aggressive drug strategy put to the test
Disease control Not yet recruitingThis study tests whether quickly starting and increasing heart failure medications in women after a hospital stay can lower the risk of death or another hospital visit within a year. About 360 women from 13 hospitals in Italy will be randomly assigned to either an intensive medic…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: IRCCS Policlinico S. Donato • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
New drug NT-88 aims to improve heart function in 60 patients
Disease control Not yet recruitingThis study tests a new drug called NT-88 in 60 adults with chronic heart failure where the heart's pumping ability is mildly reduced. The goal is to see if NT-88 is safe and can improve heart function, symptoms like shortness of breath, and fatigue. Participants will be monitored…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Guangzhou Manjing biomedicine technology co., ltd • Aim: Disease control
Last updated May 17, 2026 03:13 UTC